NEW YORK ( TheStreet) -- Quidel Corporation (Nasdaq: QDEL) hit a new 52-week high Friday as it is currently trading at $16.34, above its previous 52-week high of $16.30 with 15,725 shares traded as of 9:45 a.m. ET. Average volume has been 167,100 shares over the past 30 days. Quidel has a market cap of $515.2 million and is part of the health care sector and drugs industry. Shares are up 12.5% year to date as of the close of trading on Thursday. Quidel Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of diagnostic testing solutions for applications primarily in infectious diseases, and reproductive and women's health. The company has a P/E ratio of 517.7, below the average drugs industry P/E ratio of 776.5 and above the S&P 500 P/E ratio of 17.7.
Practice your QDEL trading strategies and win cash in our stock game.
TheStreet Ratings rates Quidel as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. You can view the full Quidel Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center.